CytoSorbents Achieves Record Revenue and Product Sales Growth in 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Cytosorbents (CTSO) Reports FY18 Loss of $0.56
March 7, 2019 4:22 PM ESTCytosorbents (NASDAQ: CTSO) reported Q4 FY18 of ($0.56), versus ($0.32) reported last year. Revenue for the year came in at $22.5 million, versus $15.15 million reported last year.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More


